VentiRx Raises Series A


VentiRx Pharmaceuticals Inc., a San Diego-based drug company initially focused on small molecule Toll-like receptor (TLR)-based therapeutics, has raised $26.6 million in Series A funding from Frazier Healthcare Ventures, ARCH Venture Partners and Domain Associates. It previously had raised a $2.3 million seed round. www.ventirx.com